Indraprastha Medical Corporation Limited (INDRAMEDCO.NS)
INR 500.05
(-0.28%)
INR 500.05
(-0.28%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 75.3 Million INR | -10.89% |
| 2022 | 84.5 Million INR | -15.42% |
| 2021 | 99.9 Million INR | 14.33% |
| 2020 | 87.38 Million INR | -27.58% |
| 2019 | 120.66 Million INR | 45.09% |
| 2018 | 83.16 Million INR | -8.86% |
| 2017 | 91.24 Million INR | -8.29% |
| 2016 | 99.48 Million INR | -22.2% |
| 2015 | 127.87 Million INR | 2.52% |
| 2014 | 124.73 Million INR | 0.81% |
| 2013 | 123.72 Million INR | 5.92% |
| 2012 | 116.81 Million INR | 13.16% |
| 2011 | 103.22 Million INR | 6.15% |
| 2010 | 97.24 Million INR | 1.33% |
| 2009 | 95.96 Million INR | 5.65% |
| 2008 | 90.83 Million INR | -4.71% |
| 2007 | 95.32 Million INR | 21.63% |
| 2006 | 78.36 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 78.6 Million INR | 0.0% |
| 2023 Q4 | 75.3 Million INR | 0.0% |
| 2023 FY | 75.3 Million INR | -10.89% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 79.6 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 84.5 Million INR | -15.42% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 104.5 Million INR | 0.0% |
| 2022 Q4 | 84.5 Million INR | 0.0% |
| 2021 Q2 | 104.01 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 99.9 Million INR | 14.33% |
| 2021 Q4 | 99.9 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 86.16 Million INR | 0.0% |
| 2020 FY | 87.38 Million INR | -27.58% |
| 2020 Q4 | 87.38 Million INR | 0.0% |
| 2019 Q2 | 83.56 Million INR | 0.0% |
| 2019 Q4 | 120.66 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 120.66 Million INR | 45.09% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 83.16 Million INR | -8.86% |
| 2018 Q4 | 83.16 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 83.74 Million INR | 0.0% |
| 2017 FY | 91.24 Million INR | -8.29% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 85.74 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 91.24 Million INR | 0.0% |
| 2016 FY | 99.48 Million INR | -22.2% |
| 2016 Q2 | 88.98 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 99.48 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 122.06 Million INR | 0.0% |
| 2015 FY | 127.87 Million INR | 2.52% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 127.87 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 124.73 Million INR | 0.81% |
| 2014 Q4 | 124.73 Million INR | 0.0% |
| 2014 Q2 | 127.92 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 123.72 Million INR | 5.92% |
| 2013 Q4 | 123.72 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 123.16 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 227.62 Million INR | 0.0% |
| 2012 FY | 116.81 Million INR | 13.16% |
| 2012 Q4 | 116.81 Million INR | 0.0% |
| 2011 FY | 103.22 Million INR | 6.15% |
| 2010 FY | 97.24 Million INR | 1.33% |
| 2009 FY | 95.96 Million INR | 5.65% |
| 2008 FY | 90.83 Million INR | -4.71% |
| 2007 FY | 95.32 Million INR | 21.63% |
| 2006 FY | 78.36 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 4.59 Billion INR | 98.362% |
| Artemis Medicare Services Limited | 100.82 Million INR | 25.318% |
| Aster DM Healthcare Limited | 1.1 Billion INR | 93.187% |
| Fortis Healthcare Limited | 1.07 Billion INR | 92.99% |
| HealthCare Global Enterprises Limited | 426.7 Million INR | 82.353% |
| Krishna Institute of Medical Sciences Limited | 494.44 Million INR | 84.771% |
| Lotus Eye Hospital and Institute Limited | 32.11 Million INR | -134.463% |
| Max Healthcare Institute Limited | 798.4 Million INR | 90.569% |
| Max India Limited | 61.3 Million INR | -22.838% |
| Global Health Limited | 668.5 Million INR | 88.736% |
| Narayana Hrudayalaya Limited | 1.09 Billion INR | 93.151% |
| Rainbow Children's Medicare Limited | 239.78 Million INR | 68.596% |
| Shalby Limited | 2.35 Billion INR | 96.798% |